Literature DB >> 15976030

Extreme hyperopia is the result of null mutations in MFRP, which encodes a Frizzled-related protein.

Olof H Sundin1, Gregory S Leppert, Eduardo D Silva, Jun-Ming Yang, Sharola Dharmaraj, Irene H Maumenee, Luisa Coutinho Santos, Cameron F Parsa, Elias I Traboulsi, Karl W Broman, Cathy Dibernardo, Janet S Sunness, Jeffrey Toy, Ethan M Weinberg.   

Abstract

Nanophthalmos is a rare disorder of eye development characterized by extreme hyperopia (farsightedness), with refractive error in the range of +8.00 to +25.00 diopters. Because the cornea and lens are normal in size and shape, hyperopia occurs because insufficient growth along the visual axis places these lensing components too close to the retina. Nanophthalmic eyes show considerable thickening of both the choroidal vascular bed and scleral coat, which provide nutritive and structural support for the retina. Thickening of these tissues is a general feature of axial hyperopia, whereas the opposite occurs in myopia. We have mapped recessive nanophthalmos to a unique locus at 11q23.3 and identified four independent mutations in MFRP, a gene that is selectively expressed in the eye and encodes a protein with homology to Tolloid proteases and the Wnt-binding domain of the Frizzled transmembrane receptors. This gene is not critical for retinal function, as patients entirely lacking MFRP can still have good refraction-corrected vision, produce clinically normal electro-retinograms, and show only modest anomalies in the dark adaptation of photoreceptors. MFRP appears primarily devoted to regulating axial length of the eye. It remains to be determined whether natural variation in its activity plays a role in common refractive errors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976030      PMCID: PMC1172243          DOI: 10.1073/pnas.0501451102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Estimation of allele frequencies with data on sibships.

Authors:  K W Broman
Journal:  Genet Epidemiol       Date:  2001-04       Impact factor: 2.135

2.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

Review 3.  Modifier genes in mice and humans.

Authors:  J H Nadeau
Journal:  Nat Rev Genet       Date:  2001-03       Impact factor: 53.242

4.  Molecular cloning and characterization of MFRP, a novel gene encoding a membrane-type Frizzled-related protein.

Authors:  M Katoh
Journal:  Biochem Biophys Res Commun       Date:  2001-03-23       Impact factor: 3.575

5.  Genetic basis of total colourblindness among the Pingelapese islanders.

Authors:  O H Sundin; J M Yang; Y Li; D Zhu; J N Hurd; T N Mitchell; E D Silva; I H Maumenee
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

Review 6.  Retinal degeneration mutants in the mouse.

Authors:  B Chang; N L Hawes; R E Hurd; M T Davisson; S Nusinowitz; J R Heckenlively
Journal:  Vision Res       Date:  2002-02       Impact factor: 1.886

7.  Comprehensive human genetic maps: individual and sex-specific variation in recombination.

Authors:  K W Broman; J C Murray; V C Sheffield; R L White; J L Weber
Journal:  Am J Hum Genet       Date:  1998-09       Impact factor: 11.025

8.  Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy.

Authors:  Johane Robitaille; Marcia L E MacDonald; Ajamete Kaykas; Laird C Sheldahl; Jutta Zeisler; Marie-Pierre Dubé; Lin-Hua Zhang; Roshni R Singaraja; Duane L Guernsey; Binyou Zheng; Lee F Siebert; Ann Hoskin-Mott; Michael T Trese; Simon N Pimstone; Barkur S Shastry; Randall T Moon; Michael R Hayden; Y Paul Goldberg; Mark E Samuels
Journal:  Nat Genet       Date:  2002-08-12       Impact factor: 38.330

9.  Mfrp, a gene encoding a frizzled related protein, is mutated in the mouse retinal degeneration 6.

Authors:  Shuhei Kameya; Norman L Hawes; Bo Chang; John R Heckenlively; Jürgen K Naggert; Patsy M Nishina
Journal:  Hum Mol Genet       Date:  2002-08-01       Impact factor: 6.150

Review 10.  Secreted antagonists of the Wnt signalling pathway.

Authors:  Yoshiaki Kawano; Robert Kypta
Journal:  J Cell Sci       Date:  2003-07-01       Impact factor: 5.285

View more
  73 in total

1.  Gene therapy for retinitis pigmentosa caused by MFRP mutations: human phenotype and preliminary proof of concept.

Authors:  Astra Dinculescu; Jackie Estreicher; Juan C Zenteno; Tomas S Aleman; Sharon B Schwartz; Wei Chieh Huang; Alejandro J Roman; Alexander Sumaroka; Qiuhong Li; Wen-Tao Deng; Seok-Hong Min; Vince A Chiodo; Andy Neeley; Xuan Liu; Xinhua Shu; Margarita Matias-Florentino; Beatriz Buentello-Volante; Sanford L Boye; Artur V Cideciyan; William W Hauswirth; Samuel G Jacobson
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

2.  Wnt signaling in eye organogenesis.

Authors:  Sabine Fuhrmann
Journal:  Organogenesis       Date:  2008-04       Impact factor: 2.500

3.  174delG mutation in mouse MFRP causes photoreceptor degeneration and RPE atrophy.

Authors:  Joseph Fogerty; Joseph C Besharse
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-14       Impact factor: 4.799

4.  Genetic modifier loci of mouse Mfrp(rd6) identified by quantitative trait locus analysis.

Authors:  Jungyeon Won; Jeremy R Charette; Vivek M Philip; Timothy M Stearns; Weidong Zhang; Jürgen K Naggert; Mark P Krebs; Patsy M Nishina
Journal:  Exp Eye Res       Date:  2013-11-04       Impact factor: 3.467

Review 5.  The genetic mechanisms of primary angle closure glaucoma.

Authors:  D F Ahram; W L Alward; M H Kuehn
Journal:  Eye (Lond)       Date:  2015-07-24       Impact factor: 3.775

6.  Clinical utility gene card for: Non-Syndromic Microphthalmia Including Next-Generation Sequencing-Based Approaches.

Authors:  Rose Richardson; Jane Sowden; Christina Gerth-Kahlert; Anthony T Moore; Mariya Moosajee
Journal:  Eur J Hum Genet       Date:  2017-01-18       Impact factor: 4.246

7.  A detailed phenotypic assessment of individuals affected by MFRP-related oculopathy.

Authors:  Rajarshi Mukhopadhyay; Panagiotis I Sergouniotis; Donna S Mackay; Alexander C Day; Genevieve Wright; Sophie Devery; Bart P Leroy; Anthony G Robson; Graham E Holder; Zheng Li; Andrew R Webster
Journal:  Mol Vis       Date:  2010-03-26       Impact factor: 2.367

8.  Enzymatic regulation of pattern: BMP4 binds CUB domains of Tolloids and inhibits proteinase activity.

Authors:  Hojoon X Lee; Fabio A Mendes; Jean-Louis Plouhinec; Edward M De Robertis
Journal:  Genes Dev       Date:  2009-11-01       Impact factor: 11.361

9.  Evaluation of MFRP as a candidate gene for high hyperopia.

Authors:  Panfeng Wang; Zhikuan Yang; Shiqiang Li; Xueshan Xiao; Xiangming Guo; Qingjiong Zhang
Journal:  Mol Vis       Date:  2009-01-23       Impact factor: 2.367

10.  Compound heterozygosity for a novel and a recurrent MFRP gene mutation in a family with the nanophthalmos-retinitis pigmentosa complex.

Authors:  Juan Carlos Zenteno; Beatriz Buentello-Volante; Miguel A Quiroz-González; Miguel A Quiroz-Reyes
Journal:  Mol Vis       Date:  2009-09-05       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.